Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
11.36
-0.74 (-6.16%)
Oct 8, 2026, 10:58 AM EDT - Market open
Turn Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Turn Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $25. The average 1-year stock price forecast is 120.17% higher than the current stock price, while the lowest is $24 (+111.36%) and the highest is $26 (+128.97%).
Price Target: $25 (+120.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Turn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lucid Capital | Lucid Capital | Buy Initiates $24 | Buy | Initiates | $24 | +111.36% | Sep 24, 2026 |
| Westpark Capital | Westpark Capital | Sell Downgrades $10 | Sell | Downgrades | $10 | -11.93% | Sep 14, 2026 |
Unknown Analyst WBB Securities No rating | WBB Securities | Sell Downgrades $6.15 → $10 | Sell | Downgrades | $6.15 → $10 | -11.93% | Sep 14, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Maintains $16 | Buy | Maintains | $16 | +40.91% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
250.00K
Revenue Next Year
2.50M
from 250.00K
Increased by 900.00%
EPS This Year
-0.10
from -0.21
EPS Next Year
-0.15
from -0.10
EPS and Forward PE are based on non-GAAP adjusted numbers.